WPRIM Management System> DCMS> Chinese Journal of Endocrinology and Metabolism> 2009> 25> 2

Volume: 25 Issue: 2

1. Effect of the unbalanced expressions of VEGF and PEDF on diabetic nephropathy Page:203—205
2. A functional analysis of short stature homeobox (SHOX) gene promoter mutation in idiopathic short stature Page:147—149
3. Influential factors on the ratio of plasma aldosterone concentration to plasma renin activity in screening primary aldosteronism Page:238—241
4. Progress of pharmacogenomic studies on anti-diabetic drugs Page:234—237
5. Effect of angiotensin receptor blocker on the expressions of NF-κB PPARγ in adipose tissue of high-fat- diet induced insulin resistant rats Page:210—211
6. Musclin gene overexpression in skeletal muscle of rats with long-term high-fat diet and its correlation with insulin resistance Page:208—209
7. Effects of the dietary fat on adipose-associated gene expressions of adipocytes in mice Page:193—196
8. Natural progression rate of glycometabalism in non-diabetic subjects aged above 40 years old-a 3 year prospective study in Pudong,Shanghai Page:179—180
9. Association of diabetic nephropathy with carotid intima-media thickness Page:172—173
10. Decrease in serum uric acid following achieving treat-to-target levels of glycemia,lipidemia and blood pressure in type 2 diabetic patients Page:168—169
11. The waist-to-height ratio cut-point for identifying metabolic syndrome among adolescents Page:156—158
12. Funcriohal analysis of novel mutations P459H and R483W in 21-hydroxylase gene Page:150—151
13. Insulin reverses fatty liver disease in diabetic mice induced with high fat diet Page:200—202
14. α-lipoic acid inhibits the effects of Iκβ kinase β on islet Page:186—188
15. Analysis of factors affecting the prognosis of patients with Graves' disease treated with antithyroid drugs Page:184—185
16. Levels of serum ferritin and hemoglobin in different stages of abnormal glycometabolism Page:170—171
17. Association of gene polymorphism in promoter region of adiponectin gene and carotid artery intima-media thickness in patients with type 2 diabetes mellitus of Fujian Page:136—138
18. The way in genetic research of the polygenic diseases Page:133—135
19. Relationship between insulin resistance and oxidative stress caused by elevated concentration of free fatty acids Page:205—207
20. Impact of human resistin on glucose uptake in adipocytes and its mechanism Page:197—199
21. Preliminary investigation on blood-sampling time during oral glucose-insulin releasing test in subjects with normal glucose tolerance Page:182—183
22. Epidemiological study of obesity in middle-aged and elderly people of Uygur and Han populations in xinjiang Page:181—182
23. Association of serum phosphohpid fatty acids with blood lipid profiles in patients with newly-diagnosed type 2 diabetes mellitus Page:176—178
24. Relationship between plasma level of endogenous secretory receptor of advanced glycation end products and oxidative stress in diabetic patients with hypertension Page:174—176
25. Changes of biochemical markers of bone turnover and bone mineral density in mid- and old-aged women Page:164—167
26. Correlation between serum uric acid and cardiovascular risk factors in Shandong coastal inhabitants Page:159—163
27. Assessing new homeostasis model assessment by Botnia clamp Page:152—155
28. Relationship between Calpain10 gene polymorphisms and diabetes in familial type 2 diabetes mellitus of Uygur in Xinjiang Page:144—146
29. Association of polymorphisms in transcription factor 7-like 2(TCF7L2) gene with type 2 diabetes in Chinese Han population Page:139—143
30. Retrospective of Acarbose (Glucobay(R)) administration experience in China and its prospectives Page:—
31. Acarbose Cardiovascular Evaluation:A new phase of hyperglycemia management in coronary heart disease Page:—
32. The prevention of cardiovascular events should begin with the focus on IGT Page:—
33. The impaired insulin secretion and β-cell failure in type 2 diabetes Page:—
34. Pancreatic β-cell and insulin secretion——plasticity and decompensation? Page:—

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.